O
CTRX

OrbiMed’s CATAMARAN CORP COM STK (CDA) CTRX Stock Holding History

OrbiMed’s Portfolio CTRX Stock Details CTRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-120,000
Closed -$7.14M – 159
2015
Q1 		$7.14M Buy
+120,000
New +$6.1M 0.06% 113

Other funds holding CTRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
EPCM
Eton Park Capital Management New York $2.28B AUM 33.59% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PRCM
Pine River Capital Management Minnetonka, Minnesota $32.9M AUM 4.47% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

OrbiMed's CTRX Position: Q2 2015 in Review

OrbiMed sold out of CATAMARAN CORP COM STK (CDA) (CTRX) in Q2 2015, closing a stake of 120,000 shares — an estimated $7.14M sold.

OrbiMed first reported a position in CTRX in Q1 2015 and held it in 1 quarter. The position peaked at $7.14M in Q1 2015. 326 funds tracked by Wall St. Rank hold CTRX as of Q2 2015.

  • OrbiMed reported no remaining CATAMARAN CORP COM STK (CDA) position as of Q2 2015 after selling out during the quarter.
  • OrbiMed sold 120,000 CATAMARAN CORP COM STK (CDA) shares in Q2 2015, an estimated $7.14M.
  • OrbiMed first reported a position in CATAMARAN CORP COM STK (CDA) in Q1 2015 and held it in 1 quarter.
  • OrbiMed's CATAMARAN CORP COM STK (CDA) position peaked at $7.14M in Q1 2015.
  • 326 funds tracked by Wall St. Rank held CATAMARAN CORP COM STK (CDA) as of Q2 2015.

Based on OrbiMed's 13F filing for Q2 2015, filed 14 Aug 2015.